You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SIRPa

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent ALK Positive Large B-Cell Lymphoma, Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between

Not yet recruiting
  • Recurrent ALK Positive Large B-Cell Lymphoma
  • +28 more
  • Biospecimen Collection
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 17, 2022

Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular

Recruiting
  • Aggressive B-Cell Non-Hodgkin Lymphoma
  • +19 more
  • CD47 Antagonist ALX148
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Non Hodgkin Lymphoma Trial in Worldwide (HMPL-523)

Recruiting
  • Non Hodgkin Lymphoma
  • Anaheim, California
  • +20 more
Oct 4, 2022

Microsatellite Stable Metastatic Colorectal Cancer Trial in Tucson, Aurora, New Brunswick (ALX148, Cetuximab, Pembrolizumab)

Recruiting
  • Microsatellite Stable Metastatic Colorectal Cancer
  • Tucson, Arizona
  • +2 more
Jul 28, 2022

Cancer Fusion Hybrids and Desmoplasia

Recruiting
  • Fusion Protein Expression
  • Bone Marrow Cells
    • Miaoli, Taiwan
      National Institute of Cancer Research, National Health Research
    May 30, 2022

    DLBCL, Diffuse Large B Cell Lymphoma Trial in Worldwide (R-pola-mini-CHP, R-mini-CHOP)

    Recruiting
    • DLBCL
    • Diffuse Large B Cell Lymphoma
    • Aalborg, Denmark
    • +44 more
    Jul 8, 2021

    Advanced Solid Tumor, Breast Cancer Trial in Atlanta (DS-1103a, T-DXd)

    Not yet recruiting
    • Advanced Solid Tumor
    • Breast Cancer
    • Atlanta, Georgia
      Emory University School of Medicine
    Mar 1, 2023

    Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-95251, Azacitidine)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • Marina Del Rey, California
    • +35 more
    Mar 11, 2022

    High Risk Neuroblastoma, Recurrent Neuroblastoma, Recurrent Osteosarcoma Trial in Canada, United States (Dinutuximab,

    Recruiting
    • High Risk Neuroblastoma
    • +4 more
    • Biospecimen Collection
    • +6 more
    • Los Angeles, California
    • +10 more
    Jan 19, 2023

    Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (R-CHOEP, DA-EPOCH-R)

    Recruiting
    • Lymphoma, Large B-Cell, Diffuse
    • R-CHOEP
    • DA-EPOCH-R
    • Aarhus, Denmark
    • +15 more
    Mar 3, 2020

    Ischemic Stroke, Stroke, Acute Trial in Worldwide (Tenecteplase, Control)

    Recruiting
    • Ischemic Stroke
    • Stroke, Acute
    • Worcester, Massachusetts
    • +82 more
    May 11, 2021

    Solid Tumors, Mycosis Fungoides, Melanoma Trial in United States (TTI-621 Monotherapy, TTI-621 + PD-1/PD-L1 Inhibitor, TTI-621 +

    Terminated
    • Solid Tumors
    • +7 more
    • TTI-621 Monotherapy
    • +4 more
    • Duarte, California
    • +6 more
    May 13, 2020

    Early Stage Breast Cancer Trial in San Francisco (Denosumab)

    Terminated
    Has Results
    • Early Stage Breast Cancer
    • San Francisco, California
      University of California San Francisco
    Dec 13, 2019

    Bladder Cancer Trial in Finland (white light TUR-BT, blue light TUR-BT, optimized MMC)

    Unknown status
    • Bladder Cancer
    • white light TUR-BT
    • +3 more
    • Helsinki, Finland
    • +9 more
    Apr 16, 2018

    Functional Voice Disorder Trial (Voice therapy, Voice therapy with carryover strategies, Control group)

    Completed
    • Functional Voice Disorder
    • Voice therapy
    • +2 more
    • (no location specified)
    Dec 18, 2017

    Clinical Importance of Filaggrin Gene Mutation for Treatment

    Unknown status
    • Atopic Dermatitis
      • Helsinki, Finland
        Skin and Allergy Hospital, Departments of Dermatology and Clinic
      Sep 18, 2012